Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms.

Saved in:
Bibliographic Details
Title: Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms.
Authors: Zargari M; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Nayak N; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Canonico M; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Patel PC; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Fedorov K; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Walsh KJ; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Kishtagari A; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Mohan SR; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Savona MR; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt University School of Medicine, Nashville, TN, USA., Ball S; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Apr; Vol. 67 (5), pp. 1152-1155. Date of Electronic Publication: 2025 Nov 26.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1029-2403
DOI:10.1080/10428194.2025.2592781